Such-Lupe

STADA securities

Below we have summarized the STADA securities currently in issue:

Code no. 725180
ISIN DE0007251803
Ticker symbol XETRA SAZ
Ticker symbol Reuters STAGn.DE
Ticker symbol Bloomberg SAZ:GR
Class Registered shares with restricted transferability and without par value
Admission Segment Prime Standard / Official Market
Freefloat 100%
Index MDAX (since July 2001)
EuroSTOXX 600 (since December 2002)
MSCI Small Cap Europe (since May 2003)
Listing Germany Frankfurt, Dusseldorf
Authorized Capital 154,432,824.00 EUR*
Authorized Capital / Shares 59,397,240*
Capital Stock 154,432,824.00 EUR*
Capital Stock / Shares 59,397,240*
*Status: 05/21/2013; including all converted STADA warrants (ISIN DE0007251845) so far. Information on the possible increase in the number of STADA shares.

Authorized capital

The Executive Board is authorized, in accordance with the resolution adopted by the Shareholders' Meeting on June 10, 2008, with the approval of the Supervisory Board, to increase the share capital of the company on one or more occasions by 10 June 2013 by up to EUR 76,346,010.00 through the issue of up to 29,363,850 registered shares with restricted transferability against contributions in cash and/or in kind. Shareholders are to be granted subscription rights. The Executive Board shall nevertheless be authorised, with the approval of the Supervisory Board, to exclude the statutory subscription rights of the shareholders in specific cases.

Click here for further details!

For information regarding the previous authorized capital click here!  

Purchase of the company's own shares

In accordance with the resolution adopted by the Annual General Meeting on June 16, 2010, the company is authorized to purchase own shares at a value of up to 10 % of the company's share capital from June 17, 2011 until June 16, 2013. As of September 30, 2012, the Company held 94,958 treasury shares (December 31, 2011: 96,391).

Click here for further details!

STADA warrants

Notice regarding STADA option bonds

Until June 2005, 75,000 partial debentures of EUR 1,000.- each were approved for official trading. The bonds were traded both with (cum; ISIN DE0001069540) and without (ex; ISIN DE0001069557) warrants attached. In accordance with the bond terms and conditions (available in German only), the partial debentures were repaid on June 26, 2005 (“due date”) at the nominal value (EUR 1,000.-). With those bonds that had been traded with warrants attached (cum), the warrants were automatically separated from the bond so that following repayment of the bond the respective number of warrants in the depot remained.

Authorisation to issue bonds with warrants and/or convertible bonds and at the same time creation of Conditional Capital 2008/II

The Executive Board is authorized, in accordance with the resolution adopted by the Shareholders' Meeting on June 10, 2008, on or before 9 June 2013, on one or more occasions,

  • to issue bonds with warrants and/or convertible bonds in an aggregate nominal amount of up to EUR 1,000,000,000.00 and with a maturity of up to 20 years through the company or through companies in which the company directly or indirectly has a majority holding, and
  • to assume the guarantee for such bonds with warrants and/or convertible bonds issued by subordinated group companies of the company

and to grant the holders or creditors of bonds with warrants and/or convertible bonds, option and/or conversion rights up to a total of 25,701,330 registered shares with restricted transferability of the company, representing a proportionate amount of the share capital of up to EUR 66,823,458.00 in accordance with the more detailed provisions of the respective terms of the bonds with warrants and/or convertible bonds.

Click here for further details!

Here we have provided you with an overview of important facts and information from strategy through business segments, sales networks and the history of STADA Arzneimittel AG. More
The management of STADA Arzneimittel AG introduce themselves! Here you will find the members of the Executive Board, the Supervisory Board and the Advisory Board. More
Here you will find corporate news and ad-hoc releases that you can read directly on your screen or download as a PDF file. Older releases are available for you in our archive. More
Notices in accordance with the German Securities Trading Act (WpHG) as well as the annual document and the annual financial statements of STADA Arzneimittel AG can be viewed here. More

 

(c) 2013 STADA Arzneimittel AG, Stadastraße 2-18, 61118 Bad Vilbel, Telefon 06101 603-0, Fax 06101 603-259, e-Mail: info@stada.de